nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.026	0.807	CbGdCrCtD
Valrubicin—Pelvic pain—Formoterol—chronic obstructive pulmonary disease	0.0205	0.0222	CcSEcCtD
Valrubicin—Pelvic pain—Arformoterol—chronic obstructive pulmonary disease	0.0205	0.0222	CcSEcCtD
Valrubicin—Doxorubicin—NOS3—chronic obstructive pulmonary disease	0.0141	0.329	CrCbGaD
Valrubicin—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.0139	0.015	CcSEcCtD
Valrubicin—Doxorubicin—NOS2—chronic obstructive pulmonary disease	0.0136	0.318	CrCbGaD
Valrubicin—Nocturia—Arformoterol—chronic obstructive pulmonary disease	0.0135	0.0146	CcSEcCtD
Valrubicin—Nocturia—Formoterol—chronic obstructive pulmonary disease	0.0135	0.0146	CcSEcCtD
Valrubicin—Vasodilation—Salbutamol—chronic obstructive pulmonary disease	0.0134	0.0145	CcSEcCtD
Valrubicin—Vasodilation procedure—Salbutamol—chronic obstructive pulmonary disease	0.0134	0.0145	CcSEcCtD
Valrubicin—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.0134	0.0145	CcSEcCtD
Valrubicin—Cystitis noninfective—Arformoterol—chronic obstructive pulmonary disease	0.0122	0.0132	CcSEcCtD
Valrubicin—Cystitis noninfective—Formoterol—chronic obstructive pulmonary disease	0.0122	0.0132	CcSEcCtD
Valrubicin—Cystitis—Formoterol—chronic obstructive pulmonary disease	0.0121	0.0131	CcSEcCtD
Valrubicin—Cystitis—Arformoterol—chronic obstructive pulmonary disease	0.0121	0.0131	CcSEcCtD
Valrubicin—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.0114	0.0123	CcSEcCtD
Valrubicin—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.0113	0.0123	CcSEcCtD
Valrubicin—Bladder pain—Arformoterol—chronic obstructive pulmonary disease	0.0113	0.0122	CcSEcCtD
Valrubicin—Bladder pain—Formoterol—chronic obstructive pulmonary disease	0.0113	0.0122	CcSEcCtD
Valrubicin—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.0107	0.0116	CcSEcCtD
Valrubicin—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.0104	0.0113	CcSEcCtD
Valrubicin—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00999	0.0108	CcSEcCtD
Valrubicin—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00971	0.0105	CcSEcCtD
Valrubicin—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00929	0.0101	CcSEcCtD
Valrubicin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00917	0.00991	CcSEcCtD
Valrubicin—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00909	0.00982	CcSEcCtD
Valrubicin—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00906	0.00979	CcSEcCtD
Valrubicin—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00876	0.00948	CcSEcCtD
Valrubicin—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00876	0.00947	CcSEcCtD
Valrubicin—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00848	0.00917	CcSEcCtD
Valrubicin—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00842	0.00911	CcSEcCtD
Valrubicin—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00818	0.00884	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.008	0.00866	CcSEcCtD
Valrubicin—Daunorubicin—CYP1A1—chronic obstructive pulmonary disease	0.00772	0.18	CrCbGaD
Valrubicin—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00766	0.00828	CcSEcCtD
Valrubicin—Daunorubicin—CYP1A2—chronic obstructive pulmonary disease	0.00744	0.173	CrCbGaD
Valrubicin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00724	0.00783	CcSEcCtD
Valrubicin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00718	0.00777	CcSEcCtD
Valrubicin—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00707	0.00765	CcSEcCtD
Valrubicin—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00707	0.00765	CcSEcCtD
Valrubicin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00695	0.00751	CcSEcCtD
Valrubicin—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00692	0.00749	CcSEcCtD
Valrubicin—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00689	0.00745	CcSEcCtD
Valrubicin—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.0068	0.00735	CcSEcCtD
Valrubicin—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.0068	0.00735	CcSEcCtD
Valrubicin—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00668	0.00722	CcSEcCtD
Valrubicin—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00667	0.00721	CcSEcCtD
Valrubicin—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00667	0.00721	CcSEcCtD
Valrubicin—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00655	0.00708	CcSEcCtD
Valrubicin—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00642	0.00694	CcSEcCtD
Valrubicin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0063	0.00682	CcSEcCtD
Valrubicin—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00629	0.00681	CcSEcCtD
Valrubicin—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00618	0.00669	CcSEcCtD
Valrubicin—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00618	0.00669	CcSEcCtD
Valrubicin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00601	0.0065	CcSEcCtD
Valrubicin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00581	0.00628	CcSEcCtD
Valrubicin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00576	0.00623	CcSEcCtD
Valrubicin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00576	0.00623	CcSEcCtD
Valrubicin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00559	0.00604	CcSEcCtD
Valrubicin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00554	0.00599	CcSEcCtD
Valrubicin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00553	0.00598	CcSEcCtD
Valrubicin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0055	0.00595	CcSEcCtD
Valrubicin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00529	0.00571	CcSEcCtD
Valrubicin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00529	0.00571	CcSEcCtD
Valrubicin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00522	0.00564	CcSEcCtD
Valrubicin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00508	0.0055	CcSEcCtD
Valrubicin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00507	0.00548	CcSEcCtD
Valrubicin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00507	0.00548	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00503	0.00544	CcSEcCtD
Valrubicin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00499	0.0054	CcSEcCtD
Valrubicin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00493	0.00533	CcSEcCtD
Valrubicin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00493	0.00533	CcSEcCtD
Valrubicin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00479	0.00518	CcSEcCtD
Valrubicin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00479	0.00518	CcSEcCtD
Valrubicin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00465	0.00503	CcSEcCtD
Valrubicin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00465	0.00503	CcSEcCtD
Valrubicin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00465	0.00503	CcSEcCtD
Valrubicin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00465	0.00503	CcSEcCtD
Valrubicin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00465	0.00503	CcSEcCtD
Valrubicin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00463	0.00501	CcSEcCtD
Valrubicin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00463	0.00501	CcSEcCtD
Valrubicin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0046	0.00497	CcSEcCtD
Valrubicin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0046	0.00497	CcSEcCtD
Valrubicin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00456	0.00493	CcSEcCtD
Valrubicin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00452	0.00489	CcSEcCtD
Valrubicin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00439	0.00475	CcSEcCtD
Valrubicin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00439	0.00475	CcSEcCtD
Valrubicin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00437	0.00472	CcSEcCtD
Valrubicin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00434	0.00469	CcSEcCtD
Valrubicin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00415	0.00448	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00406	0.00439	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00406	0.00439	CcSEcCtD
Valrubicin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00401	0.00433	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00398	0.0043	CcSEcCtD
Valrubicin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00391	0.00423	CcSEcCtD
Valrubicin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00387	0.00419	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00384	0.00415	CcSEcCtD
Valrubicin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00373	0.00403	CcSEcCtD
Valrubicin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00369	0.00399	CcSEcCtD
Valrubicin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00369	0.00399	CcSEcCtD
Valrubicin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00367	0.00397	CcSEcCtD
Valrubicin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00367	0.00397	CcSEcCtD
Valrubicin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00367	0.00397	CcSEcCtD
Valrubicin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00365	0.00395	CcSEcCtD
Valrubicin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00365	0.00394	CcSEcCtD
Valrubicin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00365	0.00394	CcSEcCtD
Valrubicin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00357	0.00386	CcSEcCtD
Valrubicin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00353	0.00381	CcSEcCtD
Valrubicin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00353	0.00381	CcSEcCtD
Valrubicin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.00381	CcSEcCtD
Valrubicin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.00381	CcSEcCtD
Valrubicin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00351	0.0038	CcSEcCtD
Valrubicin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00377	CcSEcCtD
Valrubicin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00376	CcSEcCtD
Valrubicin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00348	0.00376	CcSEcCtD
Valrubicin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00347	0.00375	CcSEcCtD
Valrubicin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00346	0.00374	CcSEcCtD
Valrubicin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00345	0.00373	CcSEcCtD
Valrubicin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00345	0.00373	CcSEcCtD
Valrubicin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00344	0.00372	CcSEcCtD
Valrubicin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00341	0.00369	CcSEcCtD
Valrubicin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.0036	CcSEcCtD
Valrubicin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.0036	CcSEcCtD
Valrubicin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00328	0.00355	CcSEcCtD
Valrubicin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.00346	CcSEcCtD
Valrubicin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0032	0.00346	CcSEcCtD
Valrubicin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00315	0.00341	CcSEcCtD
Valrubicin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00315	0.00341	CcSEcCtD
Valrubicin—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.00314	0.0975	CbGdCrCtD
Valrubicin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00313	0.00339	CcSEcCtD
Valrubicin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00309	0.00334	CcSEcCtD
Valrubicin—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.00307	0.0951	CbGdCrCtD
Valrubicin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00305	0.0033	CcSEcCtD
Valrubicin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00305	0.0033	CcSEcCtD
Valrubicin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00327	CcSEcCtD
Valrubicin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00299	0.00323	CcSEcCtD
Valrubicin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00298	0.00322	CcSEcCtD
Valrubicin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00319	CcSEcCtD
Valrubicin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00319	CcSEcCtD
Valrubicin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00312	CcSEcCtD
Valrubicin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00288	0.00312	CcSEcCtD
Valrubicin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00307	CcSEcCtD
Valrubicin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00307	CcSEcCtD
Valrubicin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00304	CcSEcCtD
Valrubicin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00304	CcSEcCtD
Valrubicin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00304	CcSEcCtD
Valrubicin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00304	CcSEcCtD
Valrubicin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00279	0.00302	CcSEcCtD
Valrubicin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00279	0.00302	CcSEcCtD
Valrubicin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00278	0.00301	CcSEcCtD
Valrubicin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00278	0.00301	CcSEcCtD
Valrubicin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00278	0.003	CcSEcCtD
Valrubicin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00298	CcSEcCtD
Valrubicin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00298	CcSEcCtD
Valrubicin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00275	0.00297	CcSEcCtD
Valrubicin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00296	CcSEcCtD
Valrubicin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00289	CcSEcCtD
Valrubicin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.00289	CcSEcCtD
Valrubicin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00287	CcSEcCtD
Valrubicin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00287	CcSEcCtD
Valrubicin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00265	0.00286	CcSEcCtD
Valrubicin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00265	0.00286	CcSEcCtD
Valrubicin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00285	CcSEcCtD
Valrubicin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00259	0.00281	CcSEcCtD
Valrubicin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.0027	CcSEcCtD
Valrubicin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00249	0.00269	CcSEcCtD
Valrubicin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.002	0.00216	CcSEcCtD
Valrubicin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00199	0.00215	CcSEcCtD
Valrubicin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00199	0.00215	CcSEcCtD
Valrubicin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00194	0.0021	CcSEcCtD
Valrubicin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00198	CcSEcCtD
Valrubicin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00181	0.00196	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.0016	0.00173	CcSEcCtD
Valrubicin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00173	CcSEcCtD
Valrubicin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00165	CcSEcCtD
Valrubicin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00165	CcSEcCtD
Valrubicin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00164	CcSEcCtD
Valrubicin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00156	CcSEcCtD
Valrubicin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Valrubicin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00143	0.00155	CcSEcCtD
Valrubicin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00139	0.0015	CcSEcCtD
Valrubicin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00139	0.0015	CcSEcCtD
Valrubicin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00136	CcSEcCtD
Valrubicin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00134	CcSEcCtD
Valrubicin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0013	CcSEcCtD
Valrubicin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00125	CcSEcCtD
Valrubicin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00121	CcSEcCtD
Valrubicin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00111	0.0012	CcSEcCtD
Valrubicin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00111	0.0012	CcSEcCtD
Valrubicin—Headache—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00119	CcSEcCtD
Valrubicin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
